Medicine & Life Sciences
Anticoagulants
100%
Thrombin
61%
Factor Xa Inhibitors
47%
Rivaroxaban
37%
betrixaban
37%
edoxaban
34%
apixaban
27%
Dabigatran
26%
Factor Xa
18%
Venous Thromboembolism
18%
Low Molecular Weight Heparin
17%
PRT064445
17%
Heparin
17%
Routine Diagnostic Tests
17%
Prothrombin Time
15%
Common Data Elements
14%
Tandem Mass Spectrometry
13%
Urine
13%
Coagulants
13%
Hemostasis
12%
Lupus Coagulation Inhibitor
12%
Drug Interactions
11%
Hemorrhage
11%
Point-of-Care Systems
11%
Thrombophilia
10%
Partial Thromboplastin Time
10%
Warfarin
9%
Catheter Ablation
9%
Hematology
8%
Centrifugation
8%
Freezing
8%
Hospital Emergency Service
8%
Hexadimethrine Bromide
8%
Atrial Fibrillation
8%
Quality Control
7%
Systematic Reviews
7%
Vitamin K
7%
High Pressure Liquid Chromatography
7%
Interleukin-2
7%
Multicenter Studies
7%
Thrombosis
6%
Heparin Lyase
6%
idarucizumab
6%
Prospective Studies
6%
Communication
6%
Meta-Analysis
6%
Healthy Volunteers
5%
ATP Binding Cassette Transporter, Subfamily B, Member 1
5%
Sensitivity and Specificity
5%
Chemical Compounds
Anticoagulant Agent
41%
Rivaroxaban
23%
Low Molecular Weight Heparin
19%
Thrombin
17%
Plasma Concentration
15%
Heparin
14%
Anticoagulant
12%
Plasma
11%
Fondaparinux
9%
Dabigatran
9%
Edoxaban
8%
Neutralization
8%
Centrifugation
7%
Coagulation
5%
Mass Spectrometry
5%
Blood Clotting Inhibitor
5%
Drug
5%
Time
5%